Edwards Lifesciences Corp Operating Cash Flow 2008-2025 | EW
What is operating cash flow?
Operating cash flow can be defined as the cash generated from a company's normal business operations, reflecting the ability to generate cash from core activities.
What is Edwards Lifesciences Corp's current operating cash flow?
Edwards Lifesciences Corp (EW) annual operating cash flow for 2024 was $542.3M, a 39.46% decline from 2023. Edwards Lifesciences Corp operating cash flow for the quarter ending September 30, 2025 was $573.7M.
What was Edwards Lifesciences Corp's operating cash flow in 2023?
Edwards Lifesciences Corp annual operating cash flow for 2023 was $895.8M, a 26.47% decline from 2022.
What was Edwards Lifesciences Corp's operating cash flow in 2022?
Edwards Lifesciences Corp annual operating cash flow for 2022 was $1.22B, a 29.67% decline from 2021.
What is Edwards Lifesciences Corp's 5-year operating cash flow CAGR?
Edwards Lifesciences Corp operating cash flow grew at a compound annual growth rate (CAGR) of 14.44% from FY2019 to FY2024, going from $1.18B to $542.3M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2024 | $542.3M | -39.5% | 10-K |
| FY2023 | $895.8M | -26.5% | 10-K |
| FY2022 | $1.22B | -29.7% | 10-K |
| FY2021 | $1.73B | +64.3% | 10-K |
| FY2020 | $1.05B | -10.9% | 10-K |
| FY2019 | $1.18B | +27.6% | 10-K |
| FY2018 | $926.7M | -7.4% | 10-K |
| FY2017 | $1.00B | +42.1% | 10-K |
| FY2016 | $704.4M | +28.1% | 10-K |
| FY2015 | $549.7M | -46.2% | 10-K |
| FY2014 | $1.02B | +116.3% | 10-K |
| FY2013 | $472.7M | +30.5% | 10-K |
| FY2012 | $362.1M | +17.5% | 10-K |
| FY2011 | $308.2M | +22.6% | 10-K |
| FY2010 | $251.4M | +52.1% | 10-K |
| FY2009 | $165.3M | +7.9% | 10-K |
| FY2008 | $153.2M | - | 10-K |